Clinical Trials Logo

Filter by:
NCT ID: NCT02032524 Completed - Clinical trials for Glycogen Storage Disease Type II Pompe Disease

Avalglucosidase Alfa Extension Study

NEO-EXT
Start date: February 27, 2014
Phase: Phase 2
Study type: Interventional

Primary Objective: Long-term safety and pharmacokinetics (PK) of avalglucosidase alfa Secondary Objective: Long-term effect of avalglucosidase alfa on pharmacodynamic variables

NCT ID: NCT02032199 Completed - Obesity Clinical Trials

Quality of Life Following Gastric Bypass Surgery.

Start date: April 2011
Phase: N/A
Study type: Observational

A central goal of health care is to maximize patient functioning and well-being. This has prompted measurement of health-related quality of life (HRQOL) that encompasses physical, psychological, and social functioning. While obese people have generally impaired HRQOL, people seeking bariatric surgery for obesity appear to have poorer HRQOL than obese individuals seeking non-surgical treatment or obese individuals not seeking weight-loss treatment. HRQOL improves significantly after bariatric surgery, but often with large individual variations in outcome. As gastric bypass is an invasive procedure with irreversible influences on eating behaviour and possible serious adverse events, it is important to identify potential risk factors for a poorer long-term result. In Denmark, bariatric surgery is free of charge for patients fulfilling the Danish Health and Medicines Authority guidelines, which until 2011 were in line with international guidelines. However, in 2011 access to surgery was dramatically restricted and the annual number of operations reduced from 0.9 per 1000 inhabitants (2010) to 0.2 per 1000 inhabitants (2012). The restrictions involved a tightening of the criteria for patients without manifest obesity comorbidities, raising lower body mass index (BMI) threshold from 40 to 50 and increasing the lower age limit from 18 to 25 years (11). It is not known whether patients fulfilling the tighter criteria benefit more from surgery than patients who only met the previous criteria. This study assessed HRQOL changes associated with Roux-en-Y gastric bypass with follow-up over an average of 22 months. The aim was to explore whether postoperative HRQOL variations were associated with identifiable socio-demographic or clinical characteristics. In particular, whether HRQOL changes differed for patients fulfilling the current Danish criteria and patients only fulfilling the previous criteria.

NCT ID: NCT02031809 Completed - Lung Neoplasms Clinical Trials

Multicentric Study VATS Major Introperative Complications

Start date: January 2014
Phase:
Study type: Observational

This study investigates the most common major complications that result in unplanned additional surgery in patients undergoing vats anatomical resections. Several high-volume European centres participate. The purpose is to quantify these major complications, discuss the steps that can be taken to prevent these events, how they can be dealt with, be it by vats or conversion

NCT ID: NCT02031432 Completed - Pain Clinical Trials

CORAL XT - Open-label Extension Trial of the CORAL Trial

CORAL XT
Start date: December 18, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this trial was to find out how well cebranopadol is tolerated and how often, and which, adverse reactions occur when it is taken every day for a longer period of time. In addition, information was collected how cebranopadol affects pain and well-being in patients suffering from cancer-related pain.

NCT ID: NCT02030873 Completed - Medical Education Clinical Trials

The Effect of Virtual Simulation Training in Mastoidectomy

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of virtual simulation training on mastoidectomy dissection performance of otorhinolaryngology trainees, to explore performance assessment using a final-product analysis approach and to explore the role of cognitive load.

NCT ID: NCT02028702 Completed - Osteoporosis Clinical Trials

Alternative Treatments for Menopausal Women

Start date: June 2012
Phase: N/A
Study type: Interventional

To investigate the reported health benefits (lipid profile, inflammatory factors, cardiovascular status and bone density) of a novel, phytoestrogen rich, Red Clover treatment on women suffering from both menopause related primary (hot flushes, night sweats, sleep disturbance and weight gain) and secondary (osteoporosis, cardiovascular and changes in lipid metabolism) symptoms.

NCT ID: NCT02028182 Completed - Contact Dermatitis Clinical Trials

Clinical Evaluation of Lyral® Dose Response Study

Start date: February 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine optimal allergen dose as the lowest concentration eliciting positive reactions in 70-90% of subjects. Frequency of positive, negative, doubtful and irritant reactions, and concordance with a corresponding reference allergens will be captured.

NCT ID: NCT02027766 Completed - Stretching Clinical Trials

Stretching and Pain Sensitivity

Start date: January 2014
Phase: N/A
Study type: Interventional

Stretching is frequently used in clinical practice to manage musculoskeletal discomfort and to prevent sports injuries. It is not known if stretching affects pain sensitivity. The purpose of this study is to investigate if a 4 week daily stretching protocol alters pain sensitivity. The investigators hypothesize that stretching reduces pain sensitivity.

NCT ID: NCT02026921 Completed - Clinical trials for Ovarian Epithelial Cancer Recurrent

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Start date: June 2004
Phase: Phase 2
Study type: Interventional

A phase II single arm study of carboplatin and docetaxel in treatment of first sensitive relapse of epithelial ovarian, peritoneal or tubal cancer. Hypothesis: Treatment with this combination in second line is safe and with a low frequency of neurologic side effect.

NCT ID: NCT02025985 Completed - Ovarian Carcinoma Clinical Trials

Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies

SIGN
Start date: April 9, 2014
Phase: Phase 2
Study type: Interventional

The primary trial objective is to determine the efficacy of KPT-330 (selinexor) in participants with advanced or metastatic gynaecological cancers by disease control rate (complete response (CR) or partial response (PR) or stable disease (SD) for at least 12 weeks, assessed according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.